{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:27:49Z","timestamp":1788488869377,"version":"build-2803163510"},"reference-count":41,"publisher":"Bioscientifica","issue":"4","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mechanisms of invasion in thyroid cancer remain poorly understood. We hypothesized that signaling via the epidermal growth factor receptor (EGFR) stimulates thyroid cancer cell invasion by altering the expression and cleavage of matrix metalloproteinases (MMPs). Papillary and follicular carcinoma cell lines were treated with EGF, the EGFR tyrosine kinase inhibitor AG1478, and the MMP inhibitors GM-6001 and Col-3. Flow cytometry was used to detect EGFR. In vitro invasion assays, gelatin zymography, and quantitative reverse transcription-PCR were used to assess the changes in invasive behavior and MMP expression and activation. All cell lines were found to overexpress functional EGFR. EGF stimulated invasion by thyroid cancer cells up to sevenfold (P &amp;lt; 0.0001), a process that was antagonized completely by AG1478 and Col-3, partially by GM-6001, but not by the serine protease inhibitor aprotinin. EGF upregulated expression of MMP-9 (2.64- to 8.89-fold, P &amp;lt; 0.0001) and membrane type-1 MMP (MT1-MMP, 1.97- to 2.67-fold, P &amp;lt; 0.0001). This effect was blocked completely by AG1478 and partially by Col-3. The activation of MMP-2 paralleled MT1-MMP expression. We demonstrate that MMPs are critical effectors of invasion in the papillary and follicular thyroid cancer cell lines studied. Invasion is regulated by signaling through EGFR, an effect mediated by augmentation of gelatinase expression and activation. MMP inhibitors and growth factor antagonists may be effective tumoristatic agents for the treatment of aggressive thyroid carcinomas.<\/jats:p>","DOI":"10.1677\/erc.1.01226","type":"journal-article","created":{"date-parts":[[2006,12,8]],"date-time":"2006-12-08T17:02:44Z","timestamp":1165597364000},"page":"1173-1183","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":56,"title":["Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2\/gelatinase A"],"prefix":"10.1530","volume":"13","author":[{"given":"Michael W","family":"Yeh","sequence":"first","affiliation":[{"name":"Endocrine Surgery Laboratory, UCSF\/Mt. Zion Medical Center, San Francisco, California 94115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Rougier","sequence":"additional","affiliation":[{"name":"1Department of Anatomy, University of California San Francisco, San Francisco, California 94143, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Woo","family":"Park","sequence":"additional","affiliation":[{"name":"Endocrine Surgery Laboratory, UCSF\/Mt. Zion Medical Center, San Francisco, California 94115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan-Yang","family":"Duh","sequence":"additional","affiliation":[{"name":"Endocrine Surgery Laboratory, UCSF\/Mt. Zion Medical Center, San Francisco, California 94115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariwil","family":"Wong","sequence":"additional","affiliation":[{"name":"Endocrine Surgery Laboratory, UCSF\/Mt. Zion Medical Center, San Francisco, California 94115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zena","family":"Werb","sequence":"additional","affiliation":[{"name":"1Department of Anatomy, University of California San Francisco, San Francisco, California 94143, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlo H","family":"Clark","sequence":"additional","affiliation":[{"name":"Endocrine Surgery Laboratory, UCSF\/Mt. Zion Medical Center, San Francisco, California 94115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"2026070905592480500_AKSLEN-AND-VARHAUG-1995","doi-asserted-by":"crossref","unstructured":"Akslen\n            LA\n           & Varhaug JE 1995 Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival. Cancer761643\u20131654.","DOI":"10.1002\/1097-0142(19951101)76:9<1643::AID-CNCR2820760922>3.0.CO;2-#"},{"key":"2026070905592480500_ALBINI-ETAL-1987","unstructured":"Albini\n            A\n          , Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM & McEwan RN 1987 A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Research473239\u20133245."},{"key":"2026070905592480500_BEHRENDTSEN-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Behrendtsen\n            O\n          , Alexander CM & Werb Z 1992 Metalloproteinases mediate extracellular matrix degradation by cells from mouse blastocyst outgrowths. Development114447\u2013456.","DOI":"10.1242\/dev.114.2.447"},{"key":"2026070905592480500_BUTLER-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Butler\n            GS\n          , Butler MJ, Atkinson SJ, Will H, Tamura T, van Westrum SS, Crabbe T, Clements J, d\u2019Ortho MP & Murphy G 1998 The TIMP2 membrane type 1 metalloproteinase \u2018receptor\u2019 regulates the concentration and efficient activation of progelatinase A. A kinetic study. Journal of Biological Chemistry273871\u2013880.","DOI":"10.1074\/jbc.273.2.871"},{"key":"2026070905592480500_CHANG-AND-WERB-2001","doi-asserted-by":"crossref","unstructured":"Chang\n            C\n           & Werb Z 2001 The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends in Cell Biology11S37\u2013S43.","DOI":"10.1016\/S0962-8924(01)82222-4"},{"key":"2026070905592480500_COUSSENS-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Coussens\n            LM\n          , Fingleton B & Matrisian LM 2002 Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science2952387\u20132392.","DOI":"10.1126\/science.1067100"},{"key":"2026070905592480500_DANCEY-AND-FREIDLIN-2003","doi-asserted-by":"crossref","unstructured":"Dancey\n            JE\n           & Freidlin B 2003 Targeting epidermalgrowth factor receptor \u2013 are we missing the mark? Lancet36262\u201364.","DOI":"10.1016\/S0140-6736(03)13810-X"},{"key":"2026070905592480500_EL-RAYES-AND-LORUSSO-2004","doi-asserted-by":"crossref","unstructured":"El-Rayes\n            BF\n           & LoRusso PM 2004 Targeting the epidermal growth factor receptor. British Journal of Cancer91418\u2013424.","DOI":"10.1038\/sj.bjc.6601921"},{"key":"2026070905592480500_FAGIN-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Fagin\n            JA\n          , Matsuo K, Karmakar A, Chen DL, Tang SH & Koeffler HP 1993 High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. Journal of Clinical Investigation91179\u2013184.","DOI":"10.1172\/JCI116168"},{"key":"2026070905592480500_GEE-AND-KNOWLDEN-2003","doi-asserted-by":"crossref","unstructured":"Gee\n            JM\n           & Knowlden JM 2003 ADAM metalloproteases and EGFR signalling. Breast Cancer Research5223\u2013224.","DOI":"10.1186\/bcr637"},{"key":"2026070905592480500_GOMEZ-ETAL-1997","unstructured":"Gomez\n            DE\n          , Alonso DF, Yoshiji H & Thorgeirsson UP 1997 Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. European Journal of Cell Biology74111\u2013122."},{"key":"2026070905592480500_HANEMAAIJER-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Hanemaaijer\n            R\n          , Visser H, Koolwijk P, Sorsa T, Salo T, Golub LM & van Hinsbergh VW 1998 Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. Advances in Dental Research12114\u2013118.","DOI":"10.1177\/08959374980120010301"},{"key":"2026070905592480500_HARVEY-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Harvey\n            P\n          , Clark IM, Jaurand MC, Warn RM & Edwards DR 2000 Hepatocyte growth factor\/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases. British Journal of Cancer831147\u20131153.","DOI":"10.1054\/bjoc.2000.1445"},{"key":"2026070905592480500_HAUGEN-1999","unstructured":"Haugen\n            BR\n          \n          1999 Management of the patient with progressive radioiodine non-responsive disease. Seminars in Surgical Oncology1634\u201341."},{"key":"2026070905592480500_HAUGEN-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Haugen\n            DR\n          , Akslen LA, Varhaug JE & Lillehaug JR 1992 Expression of c-erbB-2 protein in papillary thyroid carcinomas. British Journal of Cancer65832\u2013837.","DOI":"10.1038\/bjc.1992.177"},{"key":"2026070905592480500_HAUGEN-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Haugen\n            DR\n          , Akslen LA, Varhaug JE & Lillehaug JR 1993 Demonstration of a TGF-alpha-EGF-receptor autocrine loop and c-myc protein over-expression in papillary thyroid carcinomas. International Journal of Cancer5537\u201343.","DOI":"10.1002\/ijc.2910550108"},{"key":"2026070905592480500_HEID-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Heid\n            CA\n          , Stevens J, Livak KJ & Williams PM 1996 Real time quantitative PCR. Genome Research6986\u2013994.","DOI":"10.1101\/gr.6.10.986"},{"key":"2026070905592480500_HIPPS-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Hipps\n            DS\n          , Hembry RM, Docherty AJ, Reynolds JJ & Murphy G 1991 Purification and characterization of human 72-kDa gelatinase (type IV collagenase). Use of immunolocalisation to demonstrate the non-coordinate regulation of the 72-kDa and 95-kDa gelatinases by human fibroblasts. Biological Chemistry Hoppe-Seyler372287\u2013296.","DOI":"10.1515\/bchm3.1991.372.1.287"},{"key":"2026070905592480500_HODGSON-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Hodgson\n            NC\n          , Button J & Solorzano CC 2004 Thyroid cancer: is the incidence still increasing? Annals of Surgical Oncology111093\u20131097.","DOI":"10.1245\/ASO.2004.03.066"},{"key":"2026070905592480500_HOELTING-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Hoelting\n            T\n          , Siperstein AE, Clark OH & Duh QY 1994 Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo. Journal of Clinical Endocrinology and Metabolism79401\u2013408.","DOI":"10.1210\/jcem.79.2.8045955"},{"key":"2026070905592480500_JOHANSSON-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Johansson\n            N\n          , Ahonen M & Kahari VM 2000 Matrix metalloproteinases in tumor invasion. Cellular and Molecular Life Sciences575\u201315.","DOI":"10.1007\/s000180050495"},{"key":"2026070905592480500_JOSSART-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Jossart\n            GH\n          , Epstein HD, Shaver JK, Weier HU, Greulich KM, Tezelman S, Grossman RF, Siperstein AE, Duh QY & Clark OH 1996 Immunocytochemical detection of p53 in human thyroid carcinomas is associated with mutation and immortalization of cell lines. Journal of Clinical Endocrinology and Metabolism813498\u20133504.","DOI":"10.1210\/jcem.81.10.8855792"},{"key":"2026070905592480500_KAJIKAWA-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Kajikawa\n            K\n          , Yasui W, Sumiyoshi H, Yoshida K, Nakayama H, Ayhan A, Yokozaki H, Ito H & Tahara E 1991 Expression of epidermal growth factor in human tissues. Immunohistochemical and biochemical analysis. Virchows Archiv. A, Pathological Anatomy and Histopathology41827\u201332.","DOI":"10.1007\/BF01600241"},{"key":"2026070905592480500_MESA-JR-ETAL-2006","doi-asserted-by":"crossref","unstructured":"Mesa\n            C\n           Jr Mirza M, Mitsutake N, Sartor M, Medvedovic M, Tomlinson C, Knauf JA, Weber GF & Fagin JA 2006 Conditional activation of RET\/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix remodeling. Cancer Research666521\u20136529.","DOI":"10.1158\/0008-5472.CAN-06-0739"},{"key":"2026070905592480500_MOSMANN-1983","unstructured":"Mosmann\n            T\n          \n          1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods6555\u201363."},{"key":"2026070905592480500_NAKAMURA-ETAL-1999","unstructured":"Nakamura\n            H\n          , Ueno H, Yamashita K, Shimada T, Yamamoto E, Noguchi M, Fujimoto N, Sato H, Seiki M & Okada Y 1999 Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Cancer Research59467\u2013473."},{"key":"2026070905592480500_NICHOLSON-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Nicholson\n            RI\n          , Gee JM & Harper ME 2001 EGFR and cancer prognosis. European Journal of Cancer37S9\u2013S15.","DOI":"10.1016\/S0959-8049(01)00231-3"},{"key":"2026070905592480500_NOBUHARA-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Nobuhara\n            Y\n          , Onoda N, Yamashita Y, Yamasaki M, Ogisawa K, Takashima T, Ishikawa T & Hirakawa K 2005 Efficacy of epidermal growth factor receptor-targeted molecular therapy in anaplastic thyroid cancer cell lines. British Journal of Cancer921110\u20131116.","DOI":"10.1038\/sj.bjc.6602461"},{"key":"2026070905592480500_O-CHAROENRAT-ETAL-2000","unstructured":"O-charoenrat\n            P\n          , Modjtahedi H, Rhys-Evans P, Court WJ, Box GM & Eccles SA 2000 Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells. Cancer Research601121\u20131128."},{"key":"2026070905592480500_PIEDAGNEL-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Piedagnel\n            R\n          , Murphy G, Ronco PM & Lelongt B 1999 Matrix metalloproteinase 2 (MMP2) and MMP9 are produced by kidney collecting duct principal cells but are differentially regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor. Journal of Biological Chemistry2741614\u20131620.","DOI":"10.1074\/jbc.274.3.1614"},{"key":"2026070905592480500_PRICE-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Price\n            JT\n          , Wilson HM & Haites NE 1996 Epidermal growth factor (EGF) increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704. European Journal of Cancer32A1977\u20131982.","DOI":"10.1016\/0959-8049(96)00207-9"},{"key":"2026070905592480500_RUDEK-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Rudek\n            MA\n          , Figg WD, Dyer V, Dahut W, Turner ML, Steinberg SM, Liewehr DJ, Kohler DR, Pluda JM & Reed E 2001 Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer. Journal of Clinical Oncology19584\u2013592.","DOI":"10.1200\/JCO.2001.19.2.584"},{"key":"2026070905592480500_SALO-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Salo\n            T\n          , Lyons JG, Rahemtulla F, Birkedal-Hansen H & Larjava H 1991 Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. Journal of Biological Chemistry26611436\u201311441.","DOI":"10.1016\/S0021-9258(18)98977-5"},{"key":"2026070905592480500_SCHIFF-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Schiff\n            BA\n          , McMurphy AB, Jasser SA, Younes MN, Doan D, Yigitbasi OG, Kim S, Zhou G, Mandal M, Bekele BN et al.2004 Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer. Clinical Cancer Research108594\u20138602.","DOI":"10.1158\/1078-0432.CCR-04-0690"},{"key":"2026070905592480500_SMIT-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Smit\n            JW\n          , van der Pluijm G, Romijn HA, Lowik CW, Morreau H & Goslings BM 1999 Degradation of extracellular matrix by metastatic follicular thyroid carcinoma cell lines: role of the plasmin activation system. Thyroid9913\u2013919.","DOI":"10.1089\/thy.1999.9.913"},{"key":"2026070905592480500_SOULA-ROTHHUT-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Soula-Rothhut\n            M\n          , Coissard C, Sartelet H, Boudot C, Bellon G, Martiny L & Rothhut B 2005 The tumor suppressor PTEN inhibits EGF-induced TSP-1 and TIMP-1 expression in FTC-133 thyroid carcinoma cells. Experimental Cell Research304187\u2013201.","DOI":"10.1016\/j.yexcr.2004.10.026"},{"key":"2026070905592480500_UEDA-ETAL-1998","unstructured":"Ueda\n            M\n          , Fujii H, Yoshizawa K, Terai Y, Kumagai K, Ueki K & Ueki M 1998 Effects of EGF and TGF-alpha on invasion and proteinase expression of uterine cervical adenocarcinoma OMC-4 cells. Invasion & Metastasis18176\u2013183."},{"key":"2026070905592480500_WRIGHT-ETAL-1991","unstructured":"Wright\n            PA\n          , Lemoine NR, Goretzki PE, Wyllie FS, Bond J, Hughes C, Roher HD, Williams ED & Wynford-Thomas D 1991 Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumours. Oncogene61693\u20131697."},{"key":"2026070905592480500_YU-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Yu\n            AE\n          , Hewitt RE, Kleiner DE & Stetler-Stevenson WG 1996 Molecular regulation of cellular invasion \u2013 role of gelatinase A and TIMP-2. Biochemistry and Cell Biology74823\u2013831.","DOI":"10.1139\/o96-088"},{"key":"2026070905592480500_ZIELKE-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Zielke\n            A\n          , Tezelman S, Jossart GH, Wong M, Siperstein AE, Duh QY & Clark OH 1998 Establishment of a highly differentiated thyroid cancer cell line of Hu\u0308rthle cell origin. Thyroid8475\u2013483.","DOI":"10.1089\/thy.1998.8.475"},{"key":"2026070905592480500_ZIELKE-ETAL-1999","unstructured":"Zielke\n            A\n          , Hoffmann S, Plaul U, Duh QY, Clark OH & Rothmund M 1999 Pleiotropic effects of thyroid stimulating hormone in a differentiated thyroid cancer cell line. Studies on proliferation, thyroglobulin secretion, adhesion, migration and invasion. Experimental and Clinical Endocrinology & Diabetes107361\u2013369."}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/13\/4\/0131173.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/13\/4\/1173\/150237\/0131173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/13\/4\/1173\/150237\/0131173.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T09:59:32Z","timestamp":1783591172000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/13\/4\/1173\/26734\/Differentiated-thyroid-cancer-cell-invasion-is"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,1]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,12,1]]}},"URL":"https:\/\/doi.org\/10.1677\/erc.1.01226","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12,1]]}}}